000 01228 a2200325 4500
005 20250512210642.0
264 0 _c19830407
008 198304s 0 0 eng d
022 _a0735-1097
024 7 _a10.1016/s0735-1097(83)80018-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChatterjee, K
245 0 0 _aVasodilator therapy for acute myocardial infarction and chronic congestive heart failure.
_h[electronic resource]
260 _bJournal of the American College of Cardiology
_cJan 1983
300 _a133-53 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCaptopril
_xtherapeutic use
650 0 4 _aHeart Failure
_xdrug therapy
650 0 4 _aHemodynamics
_xdrug effects
650 0 4 _aHumans
650 0 4 _aHydralazine
_xtherapeutic use
650 0 4 _aMyocardial Infarction
_xdrug therapy
650 0 4 _aPrazosin
_xtherapeutic use
650 0 4 _aRegional Blood Flow
_xdrug effects
650 0 4 _aVasoconstriction
650 0 4 _aVasodilator Agents
_xpharmacology
700 1 _aParmley, W W
773 0 _tJournal of the American College of Cardiology
_gvol. 1
_gno. 1
_gp. 133-53
856 4 0 _uhttps://doi.org/10.1016/s0735-1097(83)80018-7
_zAvailable from publisher's website
999 _c6337991
_d6337991